New sinusoidal pump for transferring syrups, oils, creams and gels
Watson-Marlow's new Certa Plus sinusoidal pump provides a sustainable solution for shear sensitive, viscous pharmaceutical products.
Watson-Marlow Fluid Technology Group has launched its new Certa Plus pump series to provide sustainable, high-quality, versatile fluid management for the pharmaceutical industry.
Compared with conventional lobe pumps, the new sinusoidal Certa Plus technology offers pharmaceutical manufacturers lower shear, lower power consumption, full traceability, and ultimate cleanability when transferring syrups, oils, creams and gels.
Certa Plus provides virtually pulsation-free product flow with no need for ancillary dampeners. This improves both flow meter accuracy and heat exchanger efficiency. The low shear handling minimises the temperature increase of the pumped liquid, as well as improving batch consistency and final product quality.
The new pump series is capable of transferring and handling a wide range of challenging products from syrups and sugar solutions to lozenge products.
Its continuous flow and high suction support the efficient manufacture of pastille products. Syrup and sugar solutions can also be processed with ease as the seal flush reduces the risk of sugar-based products drying out at the seal.
Across pharmaceutical applications, varying temperatures result in products with varying viscosities. For example, in the production of suppositories, pumping at lower temperature means an increased viscosity of the product. The powerful suction of the Certa Plus handles both low viscous liquids such as oils, and high viscous products, such as creams and gels, with ease.
Clean in place capabilities enable ease of cleaning and allow the pump to be easily integrated into an aseptic fluid path. The pump can then be wet cleaned without dismantling and is steam sterilisable and bacteria-tight to remove the risk of residuals and contamination. Certa Plus has full aseptic certification (EHEDG Type EL Class I and EHEDG Type EL Aseptic Class I) and all components are made of FDA and USP Class VI certified raw materials.
The pump also offers an energy-efficient alternative, requiring up to 50% less power than lobe or circumferential piston pumps, greatly reducing electricity use and hence carbon footprint.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance